Alphabet Inc header image

Alphabet Inc

GOOGL

Equity

ISIN null / Valor 29798540

NASDAQ (2026-08-20)
USD 340.67-1.17%

Alphabet Inc
UMushroom community rating:

star star star star star
4.32 95 votes No rating yet
NegativeNeutralPositive

About company

Alphabet Inc., established as the parent company of Google, operates as a conglomerate holding company overseeing a collection of businesses, with Google being its largest and most well-known entity. Alphabet was created to provide a more structured organization for Google's expansive range of internet products and services, as well as to foster growth and innovation within its more speculative ventures, such as Life Sciences (focused on health technologies like glucose-sensing contact lenses) and Calico (dedicated to longevity research). Under this new structure, Alphabet aims to enhance management efficiency and focus by allowing its diverse subsidiaries to operate independently, each led by strong CEOs, while still benefiting from Alphabet's overarching strategic vision and resources. This reorganization also introduced segment reporting to improve transparency, with Google's financials being reported separately from those of other Alphabet businesses. Alphabet Inc. trades on the Nasdaq stock exchange under the symbols GOOGL and GOOG, continuing Google's legacy while aiming to push the boundaries of technology and innovation further.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (15.07.2026):

Alphabet Inc.’s results for the first quarter of 2026 (quarter ended March 31, 2026) showed strong revenue and profit acceleration driven by AI and Cloud: consolidated revenues were $109.9 billion (up 22% year‑over‑year; 19% in constant currency), net income was $62.6 billion (+81%) and diluted EPS was $5.11 (+82%), with operating margin expanding to 36.1%.

Revenues

Consolidated revenues: $109.896 billion, up 22% YoY (19% constant currency). This marked Alphabet’s 11th consecutive quarter of double‑digit growth.

Profit & EPS

Net income: $62.578 billion (+81% YoY). Diluted net income per share: $5.11 (+82% YoY).

Operating performance

Operating income: $39.696 billion (+30% YoY). Operating margin expanded 2 percentage points to 36.1%.

Google Cloud

Google Cloud revenue: $20.028 billion, up 63% YoY. Management highlighted strong GCP growth across enterprise AI solutions and infrastructure and a backlog that nearly doubled quarter‑on‑quarter to over $460 billion.

Google Services & Ads

Google Services: $89.637 billion, up 16% YoY. Search & other +19%; subscriptions, platforms & devices +19%; YouTube ads +11%.

Other income (investment gains)

Other income, net: $37.716 billion — primarily net unrealized gains on non‑marketable equity securities. The gain on equity securities increased provision for income tax and boosted net income materially (company cites a $36.9B gain impacting EPS by ~$2.35).

Cash flow & balance sheet

Net cash provided by operating activities: $45.790 billion for Q1. Capital expenditures were $35.674 billion in the quarter; Q1 free cash flow was $10.116 billion and trailing‑12‑month free cash flow was $64.429 billion. Cash & cash equivalents: $38.063 billion; total assets: $703.919 billion.

Capital allocation

Issued senior unsecured notes with net proceeds of $31.1 billion. Board declared a 5% dividend increase to $0.22 per share quarterly. No share repurchases were recorded in the quarter.

Business KPIs & AI traction

Paid subscriptions reached 350 million. Management highlighted AI adoption: Gemini processing >16 billion tokens per minute via direct API (up 60% q/q) and Gemini Enterprise paid monthly active users up 40% q/q. Waymo surpassed 500,000 fully autonomous rides per week.

Segments & costs

Segment operating income: Google Services $40.589B; Google Cloud $6.598B; Other Bets loss widened to $2.100B. Alphabet‑level activities (primarily shared AI R&D) increased to $5.391B, reflecting higher AI investments.

Summarized from source with an LLMView Source

Key figures

70.9%1Y
167%3Y
148%5Y

Performance

32.3%1Y
30.5%3Y
32.1%5Y

Volatility

Market cap

1999052 M

Market cap (USD)

Daily traded volume (Shares)

18,570,357

Daily traded volume (Shares)

1 day high/low

192.55 / 189.14

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.32

95 votes
Performance:
starstarstarstarstar
4.27
Innovation:
starstarstarstarstar
4.41
Society:
starstarstarstarstar
4.04
Nature:
starstarstarstarstar
3.73
Damien Tan
Malaysia, 03 May 2026
star star star star star
ABCDEFGHIJKLMNOPQRSTUVXYZ
Ronin Lim
UK, 29 Apr 2026
star star star star star
Strong fundamentals
Alejandro Moya
Spain, 18 Mar 2026
star star star star star
Rentabilidad moderada

EQUITIES OF THE SAME SECTOR

ParTec AG
ParTec AG ParTec AG Valor: 128128046
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
7.00%EUR 10.70
Solutiance AG
Solutiance AG Solutiance AG Valor: 123135374
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 1.25
Vera Therapeutics Inc
Vera Therapeutics Inc Vera Therapeutics Inc Valor: 111319498
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.14%USD 31.26
Amdocs Ltd
Amdocs Ltd Amdocs Ltd Valor: 922906
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.15%USD 60.90
Tenable Holdings Inc
Tenable Holdings Inc Tenable Holdings Inc Valor: 42615547
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.32%USD 34.11
Azenta Inc
Azenta Inc Azenta Inc Valor: 1568240
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.50%USD 36.51
DocuSign Inc
DocuSign Inc DocuSign Inc Valor: 41193881
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.27%USD 62.28
United Therapeutics Corp
United Therapeutics Corp United Therapeutics Corp Valor: 848383
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.54%USD 521.00
Qorvo Inc
Qorvo Inc Qorvo Inc Valor: 25588586
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.52%USD 96.31
WeRide Incorporation
WeRide Incorporation WeRide Incorporation Valor: 137181235
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 6.07